Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
The results of the 14th SWISS BRIDGE Award for Cancer Research were announced on the 30th October, 2014, in an awards ceremony in Zurich.
The award of 500,000 Swiss francs (£326,000) is awarded for outstanding projects in the field of oncology. This year, the prestigious board chose to highlight the important field of cancer immunotherapy.
The award is shared between Professor Laurence Zitvogel, from the Gustave Roussy Comprehensive Cancer Centre, France, and Professor Adrian Ochsenbein, from the Inselspital, Bern University Hospital, Switzerland.
Professor Zitvogel works on the interactions of the intestinal flora with immunotherapeutic treatments. Her current research investigates how intestinal flora can reinforce - and undermine - the effects immunotherapy.
Professor Ochsenbein studies cancer stem cells, which maintain the growth of tumours. He studies the unique environmental conditions that give rise to cancer stem cells, including the immune environment.
The SWISS BRIDGE award was presented by the Chairman of the Scientific Jury, Professor Gordon McVie of the European Institute of Oncology and ecancer.
Professor McVie said that the winners were chosen by a review of over a hundred word-class European oncology projects.
Source: SWISS BRIDGE
The World Cancer Declaration recognises that to make major reductions in premature deaths, innovative education and training opportunities for healthcare workers in all disciplines of cancer control need to improve significantly.
ecancer plays a critical part in improving access to education for medical professionals.
Every day we help doctors, nurses, patients and their advocates to further their knowledge and improve the quality of care. Please make a donation to support our ongoing work.
Thank you for your support.